{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:55Z","timestamp":1791223675781,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Alzheimer\u2019s disease (AD) is responsible for more than 80% of cases of dementia in senior individuals globally. In the current study, the role of modulation of the FGF1\/PI3K\/Akt pathway in the protective effect of tozasertib was evaluated. Experimental dementia was induced in mice by injecting streptozotocin (STZ) intracerebroventricularly. Various biochemical parameters for oxidative stress &amp; lipid peroxidation (SOD, GSH, catalase, TBARS), neuroinflammation (MPO, IL-6, IL-1 \u03b2, TNF-\u03b1, NF\u03baB), apoptotic markers (Bax, Bcl-2, Caspase-3), and memory parameters (AChE activity, \u03b21\u201340 levels) were assessed. The behavioral parameters evaluated included the Morris Water Maze test and the step-down passive avoidance test. Histological changes were assessed using H&amp;E staining. ICV STZ-induced AD resulted in increased oxidative stress, lipid peroxidation, neuroinflammation, apoptosis, and decreased learning and memory. The results showed that administration of tozasertib improved memory, decreased levels of oxidative stress, inflammatory parameters, and apoptotic markers, and improved histological parameters in a dose-dependent manner. Pre-administration of LY294002, a PI3K\/Akt pathway inhibitor, partially reversed the protective effects of Tozasertib, suggesting possible involvement of this pathway. However, as the mechanism was inferred primarily through pharmacological antagonism, further studies including direct molecular assessments (e.g. p-Akt\/t-Akt) are warranted to confirm the role of FGF1\/PI3K\/Akt signaling in Tozasertib\u2019s action.<\/jats:p>","DOI":"10.1038\/s41598-025-13920-5","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T17:10:54Z","timestamp":1754586654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Neuroprotective effect of Tozasertib in Streptozotocin-induced alzheimer\u2019s mice model"],"prefix":"10.1038","volume":"15","author":[{"given":"Darshpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjot Kaur","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suad Hamdan","family":"Almasoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad H","family":"Almehmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bshra A.","family":"Alsfouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermeen N.","family":"Welson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"issue":"2","key":"13920_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1381612827666211122153946","volume":"28","author":"P Tripathi","year":"2022","unstructured":"Tripathi, P., Shukla, P. & Bieberich, E. Theranostic applications of nanomaterials in alzheimer\u2019s disease: A multifunctional approach. Curr. Pharm. Des. 28 (2), 116\u2013132. https:\/\/doi.org\/10.2174\/1381612827666211122153946 (2022).","journal-title":"Curr. Pharm. Des."},{"issue":"3)","key":"13920_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamaneurol.2021.5216","volume":"79","author":"WJ Jansen","year":"2022","unstructured":"Jansen, W. J. et al. Prevalence estimates of amyloid abnormality across the alzheimer disease clinical spectrum. JAMA Neurol. 79 (3)), 228\u2013243. https:\/\/doi.org\/10.1001\/jamaneurol.2021.5216 (2022).","journal-title":"JAMA Neurol."},{"issue":"8","key":"13920_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41419-022-05153-5","volume":"13","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady, A., Lindholm, D., Ren, J. & Pratico, D. ER stress and UPR in alzheimer\u2019s disease: Mechanisms, pathogenesis, treatments. Cell Death Dis. 13 (8), 706. https:\/\/doi.org\/10.1038\/s41419-022-05153-5 (2022).","journal-title":"Cell Death Dis."},{"issue":"22","key":"13920_CR4","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.3390\/ijms232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri, E. et al. Alzheimer\u2019s disease: Treatment strategies and their limitations. Int. J. Mol. Sci. 23 (22), 13954. https:\/\/doi.org\/10.3390\/ijms232213954 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"13920_CR5","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl, T. et al. Role of monoamine oxidase activity in alzheimer\u2019s disease: An insight into the therapeutic potential of inhibitors. Molecules (Basel Switzerland). 26 (12), 3724. https:\/\/doi.org\/10.3390\/molecules26123724 (2021a).","journal-title":"Molecules (Basel Switzerland)"},{"issue":"1","key":"13920_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","volume":"59","author":"M Kumar","year":"2022","unstructured":"Kumar, M. & Bansal, N. Implications of phosphoinositide 3-Kinase-Akt (PI3K-Akt) pathway in the pathogenesis of alzheimer\u2019s disease. Mol. Neurobiol. 59 (1), 354\u2013385. https:\/\/doi.org\/10.1007\/s12035-021-02611-7 (2022).","journal-title":"Mol. Neurobiol."},{"key":"13920_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.biopha.2017.01.059","volume":"88","author":"A Kumar","year":"2017","unstructured":"Kumar, A. & Singh, N. Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of alzheimer\u2019s type. Biomed. Pharmacotherapy. 88, 698\u2013707. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.059 (2017a).","journal-title":"Biomed. Pharmacotherapy"},{"key":"13920_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pbb.2016.12.018","volume":"153","author":"A Kumar","year":"2017","unstructured":"Kumar, A. & Singh, N. Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia. Pharmacol. Biochem. Behav. 153, 147\u2013159. https:\/\/doi.org\/10.1016\/j.pbb.2016.12.018 (2017b).","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2 and 3 - Speci","key":"13920_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/FBP.0000000000000294","volume":"28","author":"A Kumar","year":"2017","unstructured":"Kumar, A. & Singh, N. Pharmacological activation of PKA improves memory loss and neuropathological changes in mouse model of dementia of alzheimer\u2019s type. BehavPharmacol 28 (2 and 3 - Special Issue), 187\u2013198. https:\/\/doi.org\/10.1097\/FBP.0000000000000294 (2017c).","journal-title":"BehavPharmacol"},{"key":"13920_CR10","doi-asserted-by":"publisher","first-page":"648636","DOI":"10.3389\/fphar.2021.648636","volume":"12","author":"HZ Long","year":"2021","unstructured":"Long, H. Z. et al. PI3K\/AKT signal pathway: A target of natural products in the prevention and treatment of alzheimer\u2019s disease and parkinson\u2019s disease. Front. Pharmacol. 12, 648636. https:\/\/doi.org\/10.3389\/fphar.2021.648636 (2021).","journal-title":"Front. Pharmacol."},{"issue":"6","key":"13920_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","volume":"26","author":"E Razani","year":"2021","unstructured":"Razani, E. et al. The PI3K\/Akt signaling axis in alzheimer\u2019s disease: A valuable target to stimulate or suppress? Cell. Stress Chaperones. 26 (6), 871\u2013887. https:\/\/doi.org\/10.1007\/s12192-021-01231-3 (2021).","journal-title":"Cell. Stress Chaperones"},{"issue":"4","key":"13920_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13205-021-02738-3","volume":"11","author":"M Zheng","year":"2021","unstructured":"Zheng, M. & Wang, P. Role of insulin receptor substance-1 modulating PI3K\/Akt insulin signaling pathway in alzheimer\u2019s disease. 3 Biotech. 11 (4), 179. https:\/\/doi.org\/10.1007\/s13205-021-02738-3 (2021).","journal-title":"3 Biotech."},{"key":"13920_CR13","doi-asserted-by":"publisher","unstructured":"Fang, Y., Ou, S., Wu, T., Zhou, L., Tang, H., Jiang, M. & Guo, K. Lycopene alleviates oxidative stress via the PI3K\/Akt\/Nrf2pathway in a cell model of Alzheimer\u2019s disease. PeerJ, 8, e9308 (2020). https:\/\/doi.org\/10.7717\/peerj.9308.","DOI":"10.7717\/peerj.9308"},{"issue":"11)","key":"13920_CR14","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1021\/acschemneuro.1c00043","volume":"12","author":"A Uniyal","year":"2021","unstructured":"Uniyal, A. et al. Tozasertib attenuates neuropathic pain by interfering with Aurora kinase and KIF11 mediated nociception. ACS Chem. Neurosci. 12 (11)), 1948\u20131960. https:\/\/doi.org\/10.1021\/acschemneuro.1c00043 (2021).","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"13920_CR15","doi-asserted-by":"publisher","first-page":"18053","DOI":"10.1002\/jcb.29108","volume":"120","author":"J Yi","year":"2019","unstructured":"Yi, J. et al. Upregulation of the LncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in alzheimer\u2019s disease through inactivating the PI3K\/Akt signaling pathway. J. Cell. Biochem. 120 (10), 18053\u201318065. https:\/\/doi.org\/10.1002\/jcb.29108 (2019).","journal-title":"J. Cell. Biochem."},{"key":"13920_CR16","doi-asserted-by":"publisher","unstructured":"Mehta, V., Kumar, A., Jaggi, A. S. & Singh, N. Restoration of the attenuated neuroprotective effect of ischemic post-conditioning in diabetic mice by SGLT (Sodium dependent glucose co-transporters) inhibitor Phlorizin. Current Neurovascular Research.,  17(5), 706\u2013718. (2020). https:\/\/doi.org\/10.2174\/1567202617666201214112016","DOI":"10.2174\/1567202617666201214112016"},{"key":"13920_CR17","doi-asserted-by":"publisher","unstructured":"Rani, R., Kumar, A., Jaggi, A. S. & Singh, N. Pharmacological investigations on efficacy of Phlorizin a SGLT inhibitor in mouse model of intracerebroventricularstreptozotocin induced dementia of AD type. J. Basic ClinPhysiolPharmacol., 2020, 32(6), 1057\u20131064. (2020). https:\/\/doi.org\/10.1515\/jbcpp-2020-0330","DOI":"10.1515\/jbcpp-2020-0330"},{"issue":"16(1)","key":"13920_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0160-5402(86)90027-6","volume":"1986","author":"T Kameyama","year":"1986","unstructured":"Kameyama, T., Nabeshima, T. & Kozawa, T. Step-down-type passive avoidance- and escape-learning method. Suitability for experimental amnesia models. J. Pharmacol. Methods. 1986 (16(1)), 39\u201352. https:\/\/doi.org\/10.1016\/0160-5402(86)90027-6 (1986).","journal-title":"J. Pharmacol. Methods"},{"key":"13920_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Okhawa","year":"1979","unstructured":"Okhawa, H., Ohishi, N. & Yagi, K. Assay of lipid peroxides in animal tissue by acid reaction. Anal. Biochem. 95, 351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3 (1979).","journal-title":"Anal. Biochem."},{"issue":"2","key":"13920_CR20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0003-2697(72)90335-1","volume":"46","author":"AF Boyne","year":"1972","unstructured":"Boyne, A. F. & Ellman, G. L. A methodology for analysis of tissue sulfhahydral components. Anal. Biochem. 46 (2), 639\u2013653. https:\/\/doi.org\/10.1016\/0003-2697(72)90335-1 (1972).","journal-title":"Anal. Biochem."},{"issue":"10","key":"13920_CR21","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra, H. P. & Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247 (10), 3170\u20133175. https:\/\/doi.org\/10.1016\/S0021-9258(19)45228-9 (1972).","journal-title":"J. Biol. Chem."},{"issue":"2-3","key":"13920_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(91)90067-m","volume":"196","author":"L Goth","year":"1991","unstructured":"Goth, L. A simple method for determination of serum catalase activity and revision of reference range. Clin. Chim. Acta. 196 (2-3), 143\u2013151. https:\/\/doi.org\/10.1016\/0009-8981(91)90067-m (1991).","journal-title":"Clin. Chim. Acta"},{"key":"13920_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0076-6879(90)86172-R","volume":"186","author":"MB Grisham","year":"1990","unstructured":"Grisham, M. B., Benoit, J. N. & Granger, D. N. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol. 186, 729\u2013742. https:\/\/doi.org\/10.1016\/0076-6879(90)86172-R (1990).","journal-title":"Methods Enzymol."},{"issue":"14","key":"13920_CR24","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.7150\/ijbs.85767","volume":"19","author":"C Cai","year":"2023","unstructured":"Cai, C. et al. Pgam5-mediated PHB2 dephosphorylation contributes to endotoxemia-induced myocardial dysfunction by inhibiting mitophagy and the mitochondrial unfolded protein response. Int. J. Biol. Sci. 19 (14), 4657\u20134671. https:\/\/doi.org\/10.7150\/ijbs.85767 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"13920_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman, G. L., Courtney, K. D., Valentino, A. & Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9 (1961).","journal-title":"Biochem. Pharmacol."},{"key":"13920_CR26","doi-asserted-by":"publisher","unstructured":"Banchroft, A. S. & Turner, D. R. Theory and practice of histological techniques eigth ed. Churchil Livingstone, New York, London, San Francisco, Tokyo, (2019). https:\/\/doi.org\/10.1016\/C2015-0-00143-5","DOI":"10.1016\/C2015-0-00143-5"},{"issue":"3","key":"13920_CR27","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/ijms22031413","volume":"22","author":"T Behl","year":"2021","unstructured":"Behl, T. et al. Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: Pathophysiological and therapeutic perspectives. Int. J. Mol. Sci. 22 (3), 1413. https:\/\/doi.org\/10.3390\/ijms22031413 (2021b).","journal-title":"Int. J. Mol. Sci."},{"key":"13920_CR28","doi-asserted-by":"publisher","unstructured":"Liu, S., Butler, C. A., Ayton, S., Reynolds, E. C. & Dashper, S. G. Porphyromonas gingivalis and the pathogenesis of alzheimer\u2019s disease. Crit. Rev. Microbiol. 1\u201311. https:\/\/doi.org\/10.1080\/1040841X.2022.2163613 (2023).","DOI":"10.1080\/1040841X.2022.2163613"},{"issue":"5","key":"13920_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","volume":"66","author":"KH Ashe","year":"2010","unstructured":"Ashe, K. H. & Zahs, K. R. Probing the biology of alzheimer\u2019s disease in mice. Neuron 66 (5), 631\u2013645. https:\/\/doi.org\/10.1016\/j.neuron.2010.04.031 (2010).","journal-title":"Neuron"},{"key":"13920_CR30","doi-asserted-by":"publisher","first-page":"113576","DOI":"10.1016\/j.biopha.2022.113576","volume":"154","author":"R Dai","year":"2022","unstructured":"Dai, R., Sun, Y., Su, R. & Gao, H. Anti-Alzheimer\u2019s disease potential of traditional Chinese medicinal herbs as inhibitors of BACE1 and ache enzymes. Biomed. Pharmacother. 154, 113576. https:\/\/doi.org\/10.1016\/j.biopha.2022.113576 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"13920_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnmol.2011.00019","volume":"4","author":"FJ Carvajal","year":"2011","unstructured":"Carvajal, F. J. & Inestrosa, N. C. Interactions of ache with A\u03b2 aggregates in alzheimer\u2019s brain: Therapeutic relevance of IDN 5706. Front. Mol. Neurosci. 4, 19. https:\/\/doi.org\/10.3389\/fnmol.2011.00019 (2011).","journal-title":"Front. Mol. Neurosci."},{"key":"13920_CR32","doi-asserted-by":"publisher","first-page":"107355","DOI":"10.1016\/j.compbiolchem.2020.107355","volume":"88","author":"V Kumar","year":"2020","unstructured":"Kumar, V., Saha, A. & Roy, K. In Silico modeling for dual Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in alzheimer\u2019s disease. Comput. Biol. Chem. 88, 107355. https:\/\/doi.org\/10.1016\/j.compbiolchem.2020.107355 (2020).","journal-title":"Comput. Biol. Chem."},{"key":"13920_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11011-018-0343-y","volume":"34","author":"Z Jahangiri","year":"2019","unstructured":"Jahangiri, Z., Gholamnezhad, Z. & Hosseini, M. Neuroprotective effects of exercise in rodent models of memory deficit and alzheimer\u2019s. Metab. Brain Dis. 34, 21\u201337. https:\/\/doi.org\/10.1007\/s11011-018-0343-y (2019).","journal-title":"Metab. Brain Dis."},{"key":"13920_CR34","doi-asserted-by":"publisher","unstructured":"Kim, N. et al. Transplantation of gut microbiota derived from Alzheimer\u2019s disease mouse model impairs memory function and neurogenesis in C57BL\/6 mice. Brain Behav. Immunity, 98, 357\u2013365 (2021). https:\/\/doi.org\/10.1016\/j.bbi.2021.09.002","DOI":"10.1016\/j.bbi.2021.09.002"},{"issue":"107","key":"13920_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","volume":"2021","author":"A Ionescu-Tucker","year":"2021","unstructured":"Ionescu-Tucker, A. & Cotman, C. W. Emerging roles of oxidative stress in brain aging and alzheimer\u2019s disease. Neurobiol. Aging. 2021 (107), 86\u201395. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.07.014 (2021).","journal-title":"Neurobiol. Aging"},{"key":"13920_CR36","doi-asserted-by":"publisher","first-page":"102294","DOI":"10.1016\/j.ctim.2019.102294","volume":"49","author":"L Cassidy","year":"2020","unstructured":"Cassidy, L. et al. Oxidative stress in alzheimer\u2019s disease: A review on emergent natural polyphenolic therapeutics. Complement. Ther. Med. 49, 102294. https:\/\/doi.org\/10.1016\/j.ctim.2019.102294 (2020).","journal-title":"Complement. Ther. Med."},{"issue":"44","key":"13920_CR37","doi-asserted-by":"publisher","first-page":"63250","DOI":"10.1007\/s11356-021-15189-3","volume":"28","author":"D Virk","year":"2021","unstructured":"Virk, D., Kumar, A., Jaggi, A. S. & Singh, N. Ameliorative role of rolipram, PDE-4 inhibitor, against sodium arsenite\u2013induced vascular dementia in rats. Environ. Sci. Pollut. Res. 28 (44), 63250\u201363262. https:\/\/doi.org\/10.1007\/s11356-021-15189-3 (2021).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"13920_CR38","doi-asserted-by":"publisher","unstructured":"Kumar, A. & Singh, N. Calcineurin Inhibition and Protein Kinase A Activation Limits Cognitive Dysfunction and Histopathological Damage in a Model of Dementia of the Alzheimer\u2019s Type. Curr. Neurovascul. Res., 15(3), 234\u2013245 (2018). https:\/\/doi.org\/10.2174\/1567202615666180813125125","DOI":"10.2174\/1567202615666180813125125"},{"key":"13920_CR39","doi-asserted-by":"publisher","unstructured":"Neha, Kumar, A., Jaggi, A. S., Sodhi, R. K. & Singh, N. Silymarin ameliorates memory deficits and neuropathological changes in high fat diet (HFD) induced dementia of Alzheimer\u2019s type in mouse. Naunyn Schmiedebergs Arch. Pharmacol., 387(8), 777\u2013\u200987. 2014). https:\/\/doi.org\/10.1007\/s00210-014-0990-4","DOI":"10.1007\/s00210-014-0990-4"},{"issue":"4","key":"13920_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.29252\/ibj.24.4.220","volume":"24","author":"S Mehrabadi","year":"2020","unstructured":"Mehrabadi, S. & Sadr, S. S. Assessment of probiotics mixture on memory function, inflammation markers, and oxidative stress in an alzheimer\u2019s disease model of rats. Iran. Biomed. J. 24 (4), 220. https:\/\/doi.org\/10.29252\/ibj.24.4.220 (2020).","journal-title":"Iran. Biomed. J."},{"issue":"9","key":"13920_CR41","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.tins.2021.06.007","volume":"44","author":"A Guerrero","year":"2021","unstructured":"Guerrero, A., De Strooper, B. & Arancibia-C\u00e1rcamo, I. L. Cellular senescence at the crossroads of inflammation and alzheimer\u2019s disease. Trends Neurosci. 44 (9), 714\u2013727. https:\/\/doi.org\/10.1016\/j.tins.2021.06.007 (2021).","journal-title":"Trends Neurosci."},{"issue":"3","key":"13920_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S1474-4422(18)30450-2","volume":"18","author":"MR Irwin","year":"2019","unstructured":"Irwin, M. R. & Vitiello, M. V. Implications of sleep disturbance and inflammation for alzheimer\u2019s disease dementia. Lancet Neurol. 18 (3), 296\u2013306. https:\/\/doi.org\/10.1016\/S1474-4422(18)30450-2 (2019).","journal-title":"Lancet Neurol."},{"key":"13920_CR43","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled, D., Strasser, A. & Liddell, J. R. Molecular mechanisms of cell death in neurological diseases. Cell. Death Differ. 28, 2029\u20132044. https:\/\/doi.org\/10.1038\/s41418-021-00814-y (2021).","journal-title":"Cell. Death Differ."},{"issue":"6","key":"13920_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/brainsci12060758","volume":"12","author":"HJ Xu","year":"2022","unstructured":"Xu, H. J. et al. Shen Qi Wan ameliorates learning and memory impairment induced by STZ in AD rats through PI3K\/AKT pathway. Brain Sci. 12 (6), 758. https:\/\/doi.org\/10.3390\/brainsci12060758 (2022).","journal-title":"Brain Sci."},{"issue":"9","key":"13920_CR45","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/jnen\/60.9.829","volume":"60","author":"KA Roth","year":"2001","unstructured":"Roth, K. A., Caspases, Apoptosis & Disease, A. Causation, correlation, and confusion. J. Neuropathol. Exp. Neurol. 60 (9), 829\u2013838. https:\/\/doi.org\/10.1093\/jnen\/60.9.829 (2001).","journal-title":"J. Neuropathology Experimental Neurol."},{"key":"13920_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11010-010-0709-x","volume":"351","author":"MS Ola","year":"2011","unstructured":"Ola, M. S., Nawaz, M. & Ahsan, H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol. Cell. Biochem. 351, 41\u201358 (2011).","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"13920_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ceb.2010.11.003","volume":"23","author":"GC Shore","year":"2011","unstructured":"Shore, G. C., Papa, F. R. & Oakes, S. A. Signaling cell death from the Endoplasmic reticulum stress response. Curr. Opin. Cell Biol. 23 (2), 143\u2013149 (2011).","journal-title":"Curr. Opin. Cell Biol."},{"key":"13920_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","volume":"89","author":"WA Siddiqui","year":"2015","unstructured":"Siddiqui, W. A., Ahad, A. & Ahsan, H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update. Arch. Toxicol. 89, 289\u2013317 (2015).","journal-title":"Arch. Toxicol."},{"key":"13920_CR49","doi-asserted-by":"publisher","unstructured":"Mittal, A. et al. A Systematic Review of updated mechanistic insights towards Alzheimer\u2019s disease. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) (2023). https:\/\/doi.org\/10.2174\/1871527321666220510144127","DOI":"10.2174\/1871527321666220510144127"},{"issue":"4","key":"13920_CR50","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","volume":"18","author":"AM Arranz","year":"2019","unstructured":"Arranz, A. M. & De Strooper, B. The role of astroglia in alzheimer\u2019s disease: Pathophysiology and clinical implications. Lancet Neurol. 18 (4), 406\u2013414. https:\/\/doi.org\/10.1016\/S1474-4422(18)30490-3 (2019).","journal-title":"Lancet Neurol."},{"issue":"8","key":"13920_CR51","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopsych.2020.06.029","volume":"89","author":"T Guo","year":"2021","unstructured":"Guo, T., Korman, D., Baker, S. L., Landau, S. M. & Jagust, W. J. Alzheimer\u2019s disease neuroimaging initiative. Longitudinal cognitive and biomarker measurements support a unidirectional pathway in alzheimer\u2019s disease pathophysiology. Biol. Psychiatry. 89 (8), 786\u2013794. https:\/\/doi.org\/10.1016\/j.biopsych.2020.06.029 (2021).","journal-title":"Biol. Psychiatry"},{"key":"13920_CR52","doi-asserted-by":"publisher","first-page":"117996","DOI":"10.1016\/j.lfs.2020.117996","volume":"256","author":"AADT Abeysinghe","year":"2020","unstructured":"Abeysinghe, A. A. D. T., Deshapriya, R. D. U. S. & Udawatte, C. Alzheimer\u2019s disease; A review of the pathophysiological basis and therapeutic interventions. Life Sci. 256, 117996. https:\/\/doi.org\/10.1016\/j.lfs.2020.117996 (2020).","journal-title":"Life Sci."},{"key":"13920_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pbb.2015.05.006","volume":"135","author":"A Kumar","year":"2015","unstructured":"Kumar, A., Kumar, A., Jaggi, A. S. & Singh, N. Efficacy of cilostazol a selective phosphodiesterase-3 inhibitor in rat model of streptozotocin diabetes induced vascular dementia. Pharmacol. Biochem. Behav. 135, 20\u201330. https:\/\/doi.org\/10.1016\/j.pbb.2015.05.006 (2015).","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"13920_CR54","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/jphp.13073","volume":"71","author":"AK Grewal","year":"2019","unstructured":"Grewal, A. K., Singh, N. & Singh, T. G. Neuroprotective effect of Pharmacological postconditioning on cerebral ischaemia-reperfusion-induced injury in mice. J. Pharm. Pharmacol. 71 (6), 956\u2013970. https:\/\/doi.org\/10.1111\/jphp.13073 (2019).","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"13920_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10787-022-00948-6","volume":"30","author":"A Uniyal","year":"2022","unstructured":"Uniyal, A., Gadepalli, A., Modi, A. & Tiwari, V. Modulation of KIF17\/NR2B crosstalk by Tozasertib attenuates inflammatory pain in rats. Inflammopharmacology 30 (2), 549\u2013563. https:\/\/doi.org\/10.1007\/s10787-022-00948-6 (2022).","journal-title":"Inflammopharmacology"},{"key":"13920_CR56","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuropharm.2016.04.013","volume":"108","author":"C Yin","year":"2016","unstructured":"Yin, C., Huang, G. F., Sun, X. C., Guo, Z. & Zhang, J. H. Tozasertib attenuates neuronal apoptosis via DLK\/JIP3\/MA2K7\/JNK pathway in early brain injury after SAH in rats. Neuropharmacology 108, 316\u2013323 (2016).","journal-title":"Neuropharmacology"},{"key":"13920_CR57","doi-asserted-by":"crossref","unstructured":"Pan, J. et al. The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front. Aging Neurosci., 16, 1459025. (2024).","DOI":"10.3389\/fnagi.2024.1459025"},{"key":"13920_CR58","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.yexmp.2022.104846","volume":"129","author":"A Goyal","year":"2023","unstructured":"Goyal, A., Agrawal, A., Verma, A. & Dubey, N. The PI3K-AKT pathway: A plausible therapeutic target in parkinson\u2019s disease. Exp. Mol. Pathol. 129, 104846 (2023).","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"13920_CR59","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11010-022-04587-x","volume":"478","author":"K Ramasubbu","year":"2023","unstructured":"Ramasubbu, K. & Devi Rajeswari, V. Impairment of insulin signaling pathway PI3K\/Akt\/mTOR and insulin resistance induced ages on diabetes mellitus and neurodegenerative diseases: A perspective review. Mol. Cell. Biochem. 478 (6), 1307\u20131324 (2023).","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"13920_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-025-01543-8","volume":"40","author":"H Khan","year":"2025","unstructured":"Khan, H. et al. Pharmacological modulation of PI3K\/PTEN\/Akt\/mTOR\/ERK signaling pathways in ischemic injury: A mechanistic perspective. Metab. Brain Dis. 40 (3), 1\u20139 (2025).","journal-title":"Metab. Brain Dis."},{"key":"13920_CR61","doi-asserted-by":"crossref","unstructured":"Bhatia, V., Vikram, V., Chandel, A. & Rattan, A. Interplay between PI3k\/AKT signaling and caspase pathway in alzheimer disease: Mechanism and therapeutic implications. Inflammopharmacology 15, 1\u20138 (2025).","DOI":"10.1007\/s10787-025-01715-z"},{"issue":"1","key":"13920_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7599\/hmr.2017.37.1.18","volume":"37","author":"HJ Yu","year":"2017","unstructured":"Yu, H. J. & Koh, S. H. The role of PI3K\/AKT pathway and its therapeutic possibility in alzheimer\u2019s disease. Hanyang Med. Rev. 37 (1), 18\u201324 (2017).","journal-title":"Hanyang Med. Reviews"},{"issue":"7","key":"13920_CR63","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.exger.2013.02.025","volume":"48","author":"C O\u2019Neill","year":"2013","unstructured":"O\u2019Neill, C. PI3-kinase\/Akt\/mTOR signaling: Impaired on\/off switches in aging, cognitive decline and alzheimer\u2019s disease. Exp. Gerontol. 48 (7), 647\u2013653 (2013).","journal-title":"Exp. Gerontol."},{"issue":"8","key":"13920_CR64","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/ph4081070","volume":"4","author":"D Heras-Sandoval","year":"2011","unstructured":"Heras-Sandoval, D., Avila-Mu\u00f1oz, E. & Arias, C. The phosphatidylinositol 3-kinase\/mTor pathway as a therapeutic target for brain aging and neurodegeneration. Pharmaceuticals 4 (8), 1070\u20131087 (2011).","journal-title":"Pharmaceuticals"},{"issue":"11","key":"13920_CR65","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.3390\/ijms25116200","volume":"25","author":"Z Afghah","year":"2024","unstructured":"Afghah, Z. et al. Involvement of endolysosomes and Aurora kinase A in the regulation of amyloid \u03b2 protein levels in neurons. Int. J. Mol. Sci. 25 (11), 6200 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"13920_CR66","doi-asserted-by":"publisher","first-page":"100966","DOI":"10.1016\/j.neo.2024.100966","volume":"48","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma. Neoplasia 48, 100966 (2024).","journal-title":"Neoplasia"},{"issue":"4","key":"13920_CR67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/antiox14040457","volume":"14","author":"Z Sebghatollahi","year":"2025","unstructured":"Sebghatollahi, Z. et al. Signaling pathways in oxidative Stress-Induced neurodegenerative diseases: A review of phytochemical therapeutic interventions. Antioxidants 14 (4), 457 (2025).","journal-title":"Antioxidants"},{"key":"13920_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","volume":"147","author":"T Jiang","year":"2016","unstructured":"Jiang, T., Sun, Q. & Chen, S. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in parkinson\u2019s disease and alzheimer\u2019s disease. Prog. Neurobiol. 147, 1\u20139 (2016).","journal-title":"Prog. Neurobiol."},{"issue":"23","key":"13920_CR69","doi-asserted-by":"publisher","first-page":"15330","DOI":"10.3390\/ijms232315330","volume":"23","author":"M Acosta-Martinez","year":"2022","unstructured":"Acosta-Martinez, M. & Cabail, M. Z. The PI3K\/Akt pathway in meta-inflammation. Int. J. Mol. Sci. 23 (23), 15330 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"13920_CR70","first-page":"5755","volume":"14","author":"D Liu","year":"2017","unstructured":"Liu, D. et al. Effects of PI3K\/Akt signaling pathway on the expression of TNF-\u03b1 and IL-6 in rats with cerebral ischemia-reperfusion injury. Exp. Therap. Med. 14 (6), 5755\u20135760 (2017).","journal-title":"Experimental Therapeutic Med."},{"key":"13920_CR71","unstructured":"Gao, Y., Chu, S., Li, J., Zhang, Z. & Xia, C. Fibroblast Growth Factor 1 (FGF1) Improves Neuroinflammation and Cognitive Function in a Mouse Model of Alzheimer\u2019s Disease by Activating PI3K\/Akt Signaling Pathway, 109, 1500\u20131508 (Biomedicine & Pharmacotherapy, 2019)."},{"issue":"5","key":"13920_CR72","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3892\/etm.2017.4259","volume":"13","author":"Y Meng","year":"2017","unstructured":"Meng, Y., Wang, W., Kang, J., Wang, X. & Sun, L. Role of the PI3K\/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats. Exp. Therap. Med. 13 (5), 2417\u20132422 (2017).","journal-title":"Experimental Therapeutic Med."},{"issue":"1","key":"13920_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","volume":"9","author":"G Song","year":"2005","unstructured":"Song, G., Ouyang, G. & Bao, S. The activation of akt\/pkb signaling pathway and cell survival. J. Cell. Mol. Med. 9 (1), 59\u201371 (2005).","journal-title":"J. Cell. Mol. Med."},{"key":"13920_CR74","doi-asserted-by":"crossref","unstructured":"Yu, X. et al. Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain. Nat. Commun. 11(1), 264 (2018).","DOI":"10.1038\/s41467-019-13839-2"},{"issue":"1","key":"13920_CR75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuint.2009.09.011","volume":"56","author":"E Tyagi","year":"2010","unstructured":"Tyagi, E., Agrawal, R., Nath, C. & Shukla, R. Cholinergic protection via \u03b17 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation. Neurochem. Int. 56 (1), 135\u2013142 (2010).","journal-title":"Neurochem. Int."},{"issue":"13","key":"13920_CR76","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1038\/sj.emboj.7600251","volume":"23","author":"L Baki","year":"2004","unstructured":"Baki, L. et al. PS1 activates PI3K thus inhibiting GSK-3 activity and Tau overphosphorylation: Effects of FAD mutations. EMBO J. 23 (13), 2586\u20132596 (2004).","journal-title":"EMBO J."},{"issue":"3","key":"13920_CR77","first-page":"344","volume":"20","author":"T Ma","year":"2017","unstructured":"Ma, T. et al. Suppression of eIF2\u03b1 kinases alleviates alzheimer\u2019s disease-related plasticity and memory deficits. Nat. Neurosci. 20 (3), 344\u2013355 (2017).","journal-title":"Nat. Neurosci."},{"issue":"1","key":"13920_CR78","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12964-023-01284-0","volume":"21","author":"D Tom\u00e9","year":"2023","unstructured":"Tom\u00e9, D., Dias, M. S., Correia, J. & Almeida, R. D. Fibroblast growth factor signaling in axons: From development to disease. Cell. Commun. Signal. 21 (1), 290 (2023).","journal-title":"Cell. Communication Signal."},{"key":"13920_CR79","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.1007\/s12035-019-01668-9","volume":"56","author":"T Okada","year":"2019","unstructured":"Okada, T. et al. FGF-2 attenuates neuronal apoptosis via FGFR3\/PI3k\/Akt signaling pathway after subarachnoid hemorrhage. Mol. Neurobiol. 56, 8203\u20138219 (2019).","journal-title":"Mol. Neurobiol."},{"key":"13920_CR80","doi-asserted-by":"publisher","first-page":"1136266","DOI":"10.3389\/fnins.2023.1136266","volume":"17","author":"W Zhai","year":"2023","unstructured":"Zhai, W. et al. The fibroblast growth factor system in cognitive disorders and dementia. Front. NeuroSci. 17, 1136266 (2023).","journal-title":"Front. NeuroSci."},{"issue":"1","key":"13920_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/BJ20061489","volume":"404","author":"SI Gharbi","year":"2007","unstructured":"Gharbi, S. I. et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem. J. 404 (1), 15\u201321 (2007).","journal-title":"Biochem. J."},{"issue":"8","key":"13920_CR82","first-page":"1284","volume":"11","author":"Y Di","year":"2018","unstructured":"Di, Y. & Chen, X. L. Inhibition of LY294002 in retinal neovascularization via down-regulation the PI3K\/AKT-VEGF pathway in vivo and in vitro. Int. J. Ophthalmol. 11 (8), 1284 (2018).","journal-title":"Int. J. Ophthalmol."},{"issue":"2","key":"13920_CR83","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.taap.2010.08.026","volume":"249","author":"BB Hasinoff","year":"2010","unstructured":"Hasinoff, B. B. & Patel, D. The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro. Toxicol. Appl. Pharmcol. 249 (2), 132\u2013139 (2010).","journal-title":"Toxicol. Appl. Pharmcol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13920-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13920-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13920-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:53:06Z","timestamp":1757353986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13920-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13920"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13920-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed in accordance with the ARRIVE guidelines. The experimental protocol was approved by Committee for Control and Supervision of Experimentation on Animals (CCSEA), Government of India on animal experimentation. All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}}],"article-number":"28963"}}